drugset / Trial / NCT06493578

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.

NCT06493578 ↗

Phase 2 Terminated 205 enrolled Vyne Therapeutics Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of VYN201 Gel in subjects with non-segmental vitiligo.

Timeline

Start
2024-06-04
Primary completion
2025-07-10
Completion
2025-09-30

Outcome

Outcome not reported

Stopped (Business): “Business Decision”

Drugs

EvaluationDrugModalityDoseRoute
Comparator VYN201 Unknown 1 % Topical
Comparator VYN201 Unknown 2 % Topical
Comparator VYN201 Unknown 3 % Topical

Indications